Cuts FY adj EPS guidance to 9.97-10.07 usd (Il Sole 24 Ore Radiocor) - New York , 17 Jul - Johnson & Johnson said increased its 2024 operational sales guidance to 89.2-89.6 billion dollars from 88.7-89.1 billion previously, to reflect the acquisition of Shockwave Medical.

It also cut its adjusted EPS guidance to 9.97-10.07 dollars from 10.57-10.72 dollars previously and its adjusted operational EPS guidance to 10.00-10.10 dollars from 10.60-10.75 dollars.

AAA-Hob

(RADIOCOR) 17-07-24 12:59:21 (0339) 5 NNNN